Gayer Charles K

CIK 00018001101 companyDURHAM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001800110

Recent Transactions

26 trades

Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-12-22$3.22/sh+14,142→ 892,492 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2025-12-22−50,000→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2025-12-22−14,142→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2025-12-22−10,091→ 17,409 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-12-22$5.04/sh+10,091→ 902,583 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-12-22$5.51/sh+50,000→ 952,583 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-12-19$7.41/sh−11,477→ 878,350 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-12-17+471,000→ 889,827 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2025-12-17+986,950→ 986,950 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-12-12$7.57/sh−8,181→ 418,827 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-12-19$7.39/sh−2,461→ 423,546 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-12-19+125,950→ 426,007 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2024-12-19+260,950→ 260,950 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-12-14$7.53/sh−8,251→ 300,057 total
Purchase
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-05-13$5.47/sh+30,000→ 307,533 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-12-19$6.05/sh−2,482→ 274,533 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-12-14$6.43/sh−5,840→ 277,015 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-12-14+34,000→ 282,855 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2023-12-14+158,500→ 158,500 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2022-12-19+158,500→ 158,500 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-12-19+34,000→ 245,610 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-12-15$10.90/sh−6,100→ 211,610 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2021-12-14+164,000→ 164,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-12-14+80,000→ 216,556 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-12-14+125,000→ 261,556 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2020-12-15+190,000→ 190,000 total

Companies

BIOCRYST PHARMACEUTICALS INC
President and CCO
$BCRX

Recent Filings

Address

4505 EMPEROR BLVD. SUITE 200

DURHAM, NC, 27703

View on SEC.gov